Condition
Malignant Pleural Effusion clinical trials and research
As of November 12, 2026, Find a Trial lists 7 Malignant Pleural Effusion clinical trials that are recruiting, at sites in 4 countries (most in United States (4), Egypt (1), China (1)). By phase: Phase 1 (4). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 7Clinical trials
- 4Countries
Newest Malignant Pleural Effusion clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Fast TIL therapy for cancers that have spread to the pleura, including mesothelioma | Phase 1 | Pittsburgh, Pennsylvania | Recruiting | Mar 2, 2026 |
| Fast TIL therapy for cancers that have spread to the pleura | Phase 1 | Pittsburgh, Pennsylvania | Recruiting | Sep 25, 2025 |
| Does turning patients during doxycycline pleurodesis improve success and comfort for malignant pleural effusion? | — | Cairo | Recruiting | Aug 29, 2025 |
| MT027 treatment for patients with pleural malignant tumors | Phase 1 | Beijing | Recruiting | Dec 10, 2024 |
| Infusing tocilizumab into chest and abdominal cavities for advanced cancer patients | Phase 1 | Pittsburgh, Pennsylvania | Recruiting | Aug 29, 2023 |
| Registry for pleural fluid samples from lung cancer and infection patients | — | Chapel Hill, North Carolina | Recruiting | Nov 17, 2022 |
| Oncodrivers in Pleural Fluid for NSCLC with Malignant Pleural Effusion | — | Næstved, Region Sjælland | Recruiting | Mar 19, 2021 |
All recruiting trials (7)
-
Fast TIL therapy for cancers that have spread to the pleura, including mesothelioma
This study will try a patient's own pleural T cells grown briefly in the lab and given into the chest with local IL-2 to treat people with malignant pleural effusions or pleural mesothelioma who have exhausted standard treatments.
-
Fast TIL therapy for cancers that have spread to the pleura
This treatment will try a patient's own pleural T cells, grown quickly in the lab and given into the chest with local IL-2, for adults whose cancer has spread to the pleura or for pleural mesothelioma.
-
Does turning patients during doxycycline pleurodesis improve success and comfort for malignant pleural effusion?
We will test whether turning people during doxycycline pleurodesis helps seal cancer-related pleural fluid and improves comfort.
-
MT027 treatment for patients with pleural malignant tumors
This study is testing a new treatment called MT027 for patients with pleural malignant tumors to see if it's safe and how well it works after they have already received standard treatment.
-
Infusing tocilizumab into chest and abdominal cavities for advanced cancer patients
This study is testing if giving tocilizumab directly into the chest and abdomen can help advanced cancer patients with fluid buildup feel better and respond to treatment.
-
Registry for pleural fluid samples from lung cancer and infection patients
This study is collecting fluid samples from patients with lung cancer or lung infections to see if they can help create better tests and treatments for these conditions.
-
Oncodrivers in Pleural Fluid for NSCLC with Malignant Pleural Effusion
This study tests whether PD-L1, ALK, and EGFR can be detected in pleural fluid from NSCLC patients with malignant effusion to see how common these oncodriver markers are.
Related topics
Quick answers
How many Malignant Pleural Effusion clinical trials are recruiting right now?
7, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 4 countries. The most sites are in United States (4 trials), Egypt (1 trial), China (1 trial), Denmark (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 4. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.